SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Recent filings
Filed 2026-04-01 17:13
Tx date 2026-03-31 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$56,511
+3,919 vol
$14.42 each 		64,519
Filed 2026-04-01 17:12
Tx date 2026-03-31 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
-7,838 vol 		60,600
Filed 2026-04-01 15:49
Tx date 2026-03-31 		$RX
BioSyent Inc. 		Elford, Sara
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$4,946
+343 vol
$14.42 each 		16,379
Filed 2026-04-01 15:47
Tx date 2026-03-31 		$RX
BioSyent Inc. 		Elford, Sara
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-686 vol 		9,133
Filed 2026-04-01 14:57
Tx date 2026-03-31 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$10,699
+742 vol
$14.42 each 		180,309
Filed 2026-04-01 14:51
Tx date 2026-03-31 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Rights
57 - Exercise of rights
-1,484 vol 		2,116
Filed 2026-04-01 14:22
Tx date 2026-03-31 		$RX
BioSyent Inc. 		Arcuri, Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$2,696
+187 vol
$14.42 each 		14,016
Filed 2026-04-01 14:21
Tx date 2026-03-31 		$RX
BioSyent Inc. 		Arcuri, Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
-374 vol 		13,829
Filed 2026-04-01 12:38
Tx date 2026-03-31 		$RX
BioSyent Inc. 		van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+3,808 vol 		58,295
Filed 2026-04-01 12:37
Tx date 2026-03-31 		$RX
BioSyent Inc. 		van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
-7,616 vol 		54,487
Filed 2026-04-01 10:52
Tx date 2026-03-27 		$RX
BioSyent Inc. 		Reynolds, Douglas Scott
5 - Senior Officer of Issuer
Direct Ownership
Rights
56 - Grant of rights
+2,449 vol 		2,449
Filed 2026-04-01 10:49
Tx date 2026-03-27 		$RX
BioSyent Inc. 		Reynolds, Douglas Scott
5 - Senior Officer of Issuer
Direct Ownership
Rights
00 - Opening Balance-Initial SEDI Report
Filed 2026-03-31 12:45
Tx date 2026-03-30 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,470
-100 vol
$14.70 each 		179,567
Filed 2026-03-31 10:34
Tx date 2025-12-31 		$RX
BioSyent Inc. 		MCCORMICK, MARNIE
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$11,638
+1,012 vol
$11.50 each
Filed 2026-03-31 10:28
Tx date 2025-12-31 		$RX
BioSyent Inc. 		MCCORMICK, MARNIE
5 - Senior Officer of Issuer
Direct Ownership
Rights
30 - Acquisition or disposition under a purchase/ownership plan 		$2,664
+226 vol
$11.79 each 		226
Filed 2026-03-31 10:25
Tx date 2025-12-31 		$RX
BioSyent Inc. 		MCCORMICK, MARNIE
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$11,638
+1,012 vol
$11.50 each
Filed 2026-03-30 11:05
Tx date 2026-03-30 		$RX
BioSyent Inc. 		Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-5,611.50
-387 vol
$14.50 each 		25,412
Filed 2026-03-30 11:04
Tx date 2026-03-30 		$RX
BioSyent Inc. 		Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$3,856
+622 vol
$6.20 each 		25,799
Filed 2026-03-30 11:01
Tx date 2026-03-30 		$RX
BioSyent Inc. 		Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options 		$-3,856.40
-622 vol
$6.20 each 		1,248
Filed 2026-03-30 10:14
Tx date 2026-03-30 		$RX
BioSyent Inc. 		Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-21,318.80
-1,912 vol
$11.15 each 		61,058